Global biopharmaceutical development - in-licensing of promising biologics and small molecule drug candidates

A bridge between the discovery of new molecules and their commercialisation

More...

A biopharmaceutical development company that in-licenses promising biologics and small molecule drug candidates for global development

More...

Applied research, drug delivery systems, FDA and SwissMedic inspected production facility

More...

Financing of biotechnology and pharmaceutical start-ups to create synergies with Debiopharm Group

More...

The financial arm of Debiopharm Group

More...

Debiopharm Group™, founded in 1979, is a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics.

The group has brought five products to the market.

It possesses a wealth of development expertise and is financially independent.

January 30 - February 1

Debiopharm Group will be delighted to meet you at the 9th Annual Bio Asia International Partnering Conference in Osaka, Japan

March 6-7

Debiopharm Group will be delighted to meet you at the Sachs European Life Science CEO Forum in Zürich, Switzerland

Debiopharm Group™ has been sponsoring three scientific awards for several years, two in Switzerland and one in Japan, namely:

Follow our latest
Products Pipeline

Debiopharm Group
presented At a glance

Social & Corporate
Responsibility

We support Sarah Marquis' expedition

Debiopharm on